Guest: Colleen Kelly Guest: Andrea Banty, DNP, FNP Explore this series of three modules on C difficile infection and the impact of gut dysbiosis on the development of recurrent disease with Dr. Colleen Kelly, Associate Professor of Medicine

Guest: Kathleen Moore, MD, MS HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty

Guest: James M. Cleary, MD, PhD Guest: Kathleen Madden, FNP, MSN, AOCNP, APHN This on-demand features an expert case discussion on the current landscape of gastric cancer, from patient selection to treatment management to maximize benefit. J

Guest: Kathleen Moore, MD, MS HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty

Guest: Kathleen Moore, MD, MS HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty

Guest: Kathleen Moore, MD, MS HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty

Guest: Shubham Pant, MD, MBBS HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty

Guest: Brad McGregor, MD HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these same therapies effective at treating other HER2-positive tumors? Join our faculty as t

Host: Kathleen Moore, MD, MS Guest: Susana Banerjee, MBBS, MA, FRCP, PhD Guest: Shubham Pant, MD, MBBS HER2-targeted treatments have been extensively researched and approved in breast, gastric, and non-small cell lung cancers. Are these

Host: Annie Levesque, MD, MSc Guest: Ethan A. Cowan, MD Alcohol use disorder, or AUD, is a rising health crisis that often goes undiagnosed. And many patients that are diagnosed with AUD do not receive appropriate pharmacologic intervention